Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2013; 19(23): 3649-3657
Published online Jun 21, 2013. doi: 10.3748/wjg.v19.i23.3649
Published online Jun 21, 2013. doi: 10.3748/wjg.v19.i23.3649
Factor | 5-yr survival group | 10-yr survival group | ||
Exp (B) 95%CI | P value | Exp (B) 95%CI | P value | |
Sex (men and women) | 0.787 (0.678-0.913) | 0.002 | 0.875 (0.667-1.146) | 0.332 |
Age (yr) (< 50 and ≥ 50) | 0.516 (0.462-0.575) | 0.000 | 1.097 (0.838-1.438) | 0.500 |
Diameter of largest tumor | 0.971 (0.921-1.023) | 0.274 | 0.961 (0.879-1.051) | 0.384 |
Child-Pugh classification | 0.070 (0.060-0.082) | 0.000 | 0.559 (0.334-0.938) | 0.028 |
No. of tumors | 1.452 (1.284-1.642) | 0.000 | 0.390 (0.261-0.582) | 0.000 |
Pretreatment serum AFP level | 1.041 (0.987-1.099) | 0.138 | 0.933 (0.851-1.022) | 0.137 |
Cirrhosis | 0.832 (0.775-0.893) | 0.000 | 10.539 (8.164-13.606) | 0.000 |
TNM stage | 0.739 (0.662-0.862) | 0.000 | 0.911 (0.739-1.124) | 0.384 |
Treatment methods | 1.152 (1.109-1.197) | 0.000 | 1.043 (0.975-1.115) | 0.220 |
Microvascular invasion | 1.038 (0.494-2.181) | 0.922 | 1.233 (0.396-3.838) | 0.718 |
- Citation: Wu KT, Wang CC, Lu LG, Zhang WD, Zhang FJ, Shi F, Li CX. Hepatocellular carcinoma: Clinical study of long-term survival and choice of treatment modalities. World J Gastroenterol 2013; 19(23): 3649-3657
- URL: https://www.wjgnet.com/1007-9327/full/v19/i23/3649.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i23.3649